Xiaolin Lu Selected Research

Therapeutics

5/2021	Pazopanib together with 6-8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma.
1/2020	Palladium nanosheet-knotted injectable hydrogels formed via palladium-sulfur bonding for synergistic chemo-photothermal therapy.
1/2020	Anionic food color tartrazine enhances antibacterial efficacy of histatin-derived peptide DHVAR4 by fine-tuning its membrane activity.
11/2019	High-resolution bimodal imaging and potent antibiotic/photodynamic synergistic therapy for osteomyelitis with a bacterial inflammation-specific versatile agent.
3/2019	Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.
1/2019	Synthesis of 5-Alkynyltetrandrine Derivatives and Evaluation of their Anticancer Activity on A549 Cell Lines.
12/2018	Cost analysis for different sequential treatment regimens for metastatic renal cell carcinoma in China.
5/2018	Ag-Hybridized plasmonic Au-triangular nanoplates: highly sensitive photoacoustic/Raman evaluation and improved antibacterial/photothermal combination therapy.
1/2015	Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
11/2014	Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaolin Lu Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 04/2003
11	Neural Tube Defects (Exencephaly) 01/2023 - 06/2011
10	Carcinogenesis 01/2017 - 08/2013
8	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
5	Infections 02/2024 - 05/2018
5	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2015
4	Renal Cell Carcinoma (Grawitz Tumor) 05/2021 - 01/2016
4	Inflammation (Inflammations) 01/2021 - 01/2015
2	Necrosis 04/2024 - 03/2024
2	Glioma (Gliomas) 02/2024 - 11/2023
2	Folic Acid Deficiency (Folic Acid Deficiencies) 01/2023 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2021
2	Osteosarcoma (Osteogenic Sarcoma) 03/2020 - 01/2017
2	Skin Neoplasms (Skin Cancer) 07/2016 - 09/2015
2	Hypoxia (Hypoxemia) 01/2016 - 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024
1	Periodontitis 02/2024
1	Disease Progression 01/2023
1	Encephalocele (Encephalocele, Frontal) 01/2023
1	Multiple Myeloma 01/2023
1	Spinal Dysraphism (Spina Bifida) 10/2022
1	Osteoporosis 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 12/2021
1	Facies 06/2021
1	Hemolysis 02/2021
1	Diabetes Complications 01/2021
1	Hyperthermia 01/2020
1	Congenital Heart Defects (Congenital Heart Defect) 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Spontaneous Abortion (Miscarriage) 01/2020
1	Polyps 01/2020
1	Osteomyelitis 11/2019
1	Communicable Diseases (Infectious Diseases) 11/2019
1	Myelitis 11/2019
1	Vascular Diseases (Vascular Disease) 10/2019

Drug/Important Bio-Agent (IBA)

10	MicroRNAs (MicroRNA)IBA 01/2023 - 08/2013
9	arseniteIBA 01/2017 - 01/2015
7	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2016
6	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 03/2013
6	Long Noncoding RNAIBA 12/2021 - 01/2015
6	Biomarkers (Surrogate Marker)IBA 03/2020 - 05/2015
4	SmokeIBA 02/2016 - 01/2015
3	Caspase 3 (Caspase-3)IBA 04/2024 - 05/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 11/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
3	CarcinogensIBA 02/2016 - 08/2013
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 04/2024 - 07/2016
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2012
2	LuciferasesIBA 01/2022 - 04/2003
2	Sorafenib (BAY 43-9006)FDA Link 12/2018 - 01/2015
2	Sunitinib (Sutent)FDA Link 12/2018 - 05/2016
2	ArsenicIBA 02/2016 - 01/2015
2	IntegrinsIBA 01/2016 - 05/2009
1	enfortumab vedotinIBA 04/2024
1	Immunoconjugates (Immunoconjugate)IBA 04/2024
1	Chloroquine (Aralen)FDA LinkGeneric 04/2024
1	CaspasesIBA 04/2024
1	EnzymesIBA 03/2024
1	ImmunosorbentsIBA 03/2024
1	benzamideIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Bortezomib (Velcade)FDA Link 01/2023
1	Melphalan (Alkeran)FDA LinkGeneric 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	daratumumabIBA 01/2023
1	Estrogens (Estrogen)FDA Link 02/2022
1	Estrogen ReceptorsIBA 02/2022
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 02/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	Pentacyclic TriterpenesIBA 06/2021
1	ClayIBA 06/2021
1	pazopanib FDA Link 05/2021
1	sintilimabIBA 05/2021
1	InflammasomesIBA 01/2021
1	SirtuinsIBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	HydrogelsIBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2020
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	snRNP Core ProteinsIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Nanog Homeobox ProteinIBA 11/2019
1	gentamicin AIBA 11/2019
1	ManganeseIBA 11/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 11/2019
1	Bovine Serum AlbuminIBA 11/2019
1	SolutionsIBA 10/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2019
1	LysophospholipidsIBA 10/2019

Therapy/Procedure

10	Therapeutics 05/2021 - 11/2014
2	Precision Medicine 02/2021 - 11/2019
2	Lasers (Laser) 01/2020 - 06/2014
1	Transplantation 02/2022
1	Injections 01/2020
1	Intravenous Injections 11/2019
1	Photochemotherapy (Photodynamic Therapy) 11/2019